3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
24
OTHER
18
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Pancreatic Neoplasms
5
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Precancerous Conditions
1
Papillomavirus Infections
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Adenocarcinoma
1
Interventions
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Surveys and Questionnaires
2
Proton Therapy
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Music Therapy
2
Mesna
2
Melphalan
2
Interviews as Topic
2
Gene Expression Profiling
2
Cyclophosphamide
2
Busulfan
2
tremelimumab
1
motesanib diphosphate
1
luprolide acetate gel depot
1
liposomal amphotericin B
1
durvalumab
1
copanlisib
1
chlorhexidine gluconate
1
batifiban
1
Whole Genome Sequencing
1
Watchful Waiting
1
Thrombopoietin
1
Taxes
1
Spermine Synthase
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Neoplasms
×
Albumin-Bound Paclitaxel
×
Clear all
NCT01746225
2023-06-01
SNAP
ETOP IBCSG Partners Foundation
Phase 2
Completed
258 enrolled
17 charts